We're Ready To Help Call us to schedule an appointment or contact us online 
|
|
|
When the normal process of blood-cell growth and development (hematopoiesis) breaks down, a malignancy of the blood cells can arise, and one or another type of blood cell can be produced in abnormally large quantities.
Team Approach to Care
At Memorial Sloan-Kettering Cancer Center, state-of-the-art treatment for a variety of cancers that develop in the bone marrow, blood, or lymph nodes is carried out by the approximately 15 experts on the Hematology Disease Management Team. Each of the team members is experienced in the use of conventional and experimental chemotherapeutic approaches, as well as the use of either high-dose chemotherapy or radiation therapy, which can be the most effective treatments for these types of cancer.
Broad Expertise
Our team provides primary care for patients with a broad range of hematologic disorders, including patients with lymphoma who are eligible for autologous stem cell transplantation, patients with multiple myeloma who are receiving standard therapy as well as stem cell transplantation, and patients with unusual hematologic disorders requiring specialized therapy. The team provides high-dose chemotherapy treatments for lymphoma, leukemia, amyloidosis, and multiple myeloma and, in addition, treats a variety of other blood disorders characterized by the overproduction or underproduction of certain types of blood cells, including myelodysplasia and aplastic anemia.
